Apollo Endosurgery (APEN) Prices 8.4M Share Common Stock Offering at $7.75/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
Go back to Apollo Endosurgery (APEN) Prices 8.4M Share Common Stock Offering at $7.75/sh
October 12, 2021 6:11 PM EDT
After-Hours Stock Movers:
Regulus Therapeutics Inc. (Nasdaq: RGLS) 25% LOWER; announced the prioritization of its promising, next-generation candidate, RGLS8429, for the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The Company recently completed the dosing period of the in-life portion of the IND-enabling toxicity studies for RGLS8429; anticipates submitting an Investigational New Drug application (IND); and subject to U.S. Food and Drug Administration (FDA) clearance, initiating a phase 1 study in the second quarter of 2022.
Neuronetics, Inc. (NASDAQ: STIM)... More
October 12, 2021 4:02 PM EDT
Apollo Endosurgery, Inc. ("Apollo") (NASDAQ: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the common stock is being offered by Apollo. In addition, Apollo expects to grant the underwriters a 30-day option to purchase additional shares of common stock.
Apollo intends to use the net proceeds of the proposed offering to invest in opportunities to drive growth, such as expanding sales and marketing programs,... More
